Half-year report · Q2
7634.TEDINET S100UQCU
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥14.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥881m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥879m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥925m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥908m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥925m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥914m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥623m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥621m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥634m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥623m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥23.6bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥23.0bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥21.7bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.6bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥17.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥16.4bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.1bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.0bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥976m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥967m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥745m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥601m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥412m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥903m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥454m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥199.7 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥450.7 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥199.16 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 75.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥490m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥490m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥62m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥581m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥581m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥20m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥400m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥850m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥806m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥107m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥291m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥174m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥174m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥783,000 |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥6.8bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥6.8bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥819m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥881m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥562m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥562m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥79m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥606m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥606m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥21m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥380m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥678m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥658m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥122m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥264m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥174m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥174m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥13m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥6.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥6.4bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥800m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥19m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥879m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 504
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |